Literature DB >> 9372243

Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.

M R Miglarese1, R Halaban, N W Gibson.   

Abstract

Dysregulated expression of basic fibroblast growth factor [fibroblast growth factor 2 (FGF-2)] mediates autocrine growth of melanoma cells. The presence of a consensus Myb binding site in the human FGF-2 promoter prompted us to investigate whether this transcription factor could regulate FGF-2 expression in melanomas. We report that c-MYB mRNA is overexpressed in melanoma cell lines compared to normal melanocytes and that ectopic expression of murine c-Myb in SK-MEL-2 human melanoma cells resulted in increased expression of FGF-2 mRNA and FGF-2 protein. Furthermore, murine c-Myb transactivated a reporter plasmid containing the human FGF-2 promoter region in contransfected SK-MEL-2 human melanoma cells. Although a functional DNA-binding domain was required for transactivation, responsiveness to c-Myb was independent of the putative Myb binding site and mapped to two regions of the FGF-2 promoter that did not bind c-Myb in vitro. We suggest that c-MYB contributes to FGF-2-mediated autocrine growth of melanomas by indirectly regulating the FGF-2 promoter.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372243

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  5 in total

1.  A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Authors:  Patrick M Dillon; Gina R Petroni; Bethany J Horton; Christopher A Moskaluk; Paula M Fracasso; Michael G Douvas; Nikole Varhegyi; Snjezana Zaja-Milatovic; Christopher Y Thomas
Journal:  Clin Cancer Res       Date:  2017-04-04       Impact factor: 12.531

Review 2.  Systemic therapies for salivary gland adenoid cystic carcinoma.

Authors:  Sosuke Sahara; Alexandra E Herzog; Jacques E Nör
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

3.  Mutation signature of adenoid cystic carcinoma: evidence for transcriptional and epigenetic reprogramming.

Authors:  Henry F Frierson; Christopher A Moskaluk
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

4.  Deregulated E2F transcriptional activity in autonomously growing melanoma cells.

Authors:  R Halaban; E Cheng; Y Smicun; J Germino
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

Review 5.  Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.

Authors:  Wendell G Yarbrough; Alexander Panaccione; Michael T Chang; Sergey V Ivanov
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.